UQ researchers use new dosing technology to enhance ICU antibiotic treatment

FHS
March 24, 2024
10:09 am

University of Queensland researchers have used dosing software to accelerate the effects of antibiotics in patients being treated for sepsis in Intensive Care Units.

Pharmalittle: We’re reading about GLP-1 spending, biosimilar patient costs, and more

Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far. It is, after all, an accomplishment worth noting. And

April 24, 2024

Low-level arsenic exposure in water linked to increased heart disease risk

Research shows long-term arsenic exposure in drinking water raises ischemic heart disease risk by 42%, emphasizing the need for stricter water safety standards.

October 25, 2024

J&J’s major depressive disorder drug hits endpoints in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.